Skip to main content
. 2019 Nov 1;44(3):426–435. doi: 10.4093/dmj.2019.0068

Table 2. Baseline characteristics according to NODM status.

Characteristic NODM (–) (n=77,053) NODM (+) (n=1,159) P value
Age, yr 38.3±5.5 41.4±5.7 <0.001
Male sex 45,222 (58.7) 926 (79.9) <0.001
Body mass index, kg/m2 23.2±3.2 26.2±3.7 <0.001
Waist circumference, cm 81.5±9.2 89.7±9.8 <0.001
Systolic blood pressure, mm Hg 109.1±13.0 117.9±13.4 <0.001
Diastolic blood pressure, mm Hg 70.1±10.1 76.6±10.8 <0.001
Total cholesterol, mmol/L 5.0±0.9 5.2±1.0 <0.001
Triglycerides, mmol/L 1.1 (0.7–1.6) 1.6 (1.1–2.4) <0.001
LDL-C, mmol/L 3.1±0.8 3.5±0.9 <0.001
HDL-C, mmol/L 1.5±0.4 1.3±0.3 <0.001
Blood urea nitrogen, mmol/L 4.4±1.1 4.7±1.1 <0.001
Creatinine, μmol/L 77.3±16.3 82.5±14.8 <0.001
Uric acid, μmol/L 315.4±87.1 357.4±87.1 <0.001
hs-CRP, mg/L 0.4 (0.2–0.8) 0.8 (0.4–1.5) <0.001
Glucose, mmol/L 5.2±0.5 6.0±0.6 <0.001
HbA1c, % (mmol/mol) 5.6±0.3 (38±0.8) 6.0±0.3 (42±0.8) <0.001
HOMA-IR 1.1 (0.7–1.7) 1.9 (1.2–2.9) <0.001
Urinary cotinine, ng/mL 0.0 (0.0–0.0) 0.0 (0.0–692.0) <0.001
Daily alcohol consumption, g/day 6.0 (3.0–17.0) 13.0 (4.0–34.0) <0.001
Alcohol consumption (≥3 times/wk) 9,855/71,303 (13.8) 235/1,078 (21.8) <0.001
Vigorous exercise (≥5 times/wk) 2,820/74,587 (3.8) 42/1,108 (3.8) 0.946
Metabolic syndrome 5,646/58,655 (9.6) 368/819 (44.9) <0.001
Hypertension 5,007/76,899 (6.5) 230/1,153 (19.9) <0.001
Self-reported smoking status <0.001
 Never smoker 36,931/66,150 (55.8) 334/991 (33.7)
 Former smoker 12,254/66,150 (18.5) 245/991 (24.7)
 Current smoker 16,965/66,150 (25.6) 412/991 (41.6)
Cotinine-verified smoking status <0.001
 Current non-smoker 59,129 (76.7) 714 (61.6)
 Current smoker 17,924 (23.3) 445 (38.4)

Values are presented as mean±standard deviation, number (%), or median (interquartile range). Triglyceride, hs-CRP, cotinine, daily alcohol amount, and HOMA-IR were log-transformed for this analysis. P values were based on Student's t-test or chi-square test.

NODM, new-onset diabetes mellitus; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostasis model assessment of insulin resistance.